?> Multi-asset income investing: MATE plc delivers positive return on net assets - DirectorsTalk

Multi-asset income investing: MATE plc delivers positive return on net assets

JPMorgan Multi-Asset Growth & Income plc (LON:MATE) published their commentary for December 2021. 

Month in review

The trust delivered a positive return on net assets in December.

Our bespoke equity sleeve – which is run by the JPMAM International Equity Group – provided the biggest positive contribution. Our regional positioning through index futures in North America and Japan was also additive to absolute performance. In contrast, European equity exposure detracted. From an asset allocation perspective, we continued to hold significant equity exposure. We increased our European small cap position and added to our US equity exposure due to the strong earnings quality of companies in the region. Finally, given concerns around the spread of Omicron and potential economic restrictions, we lowered UK equity exposure.

In fixed income, returns were flat in aggregate, with high yield and emerging market debt providing positive contributions to absolute returns.

Our convertible bond fund holding posted a negative return in absolute terms and lagged the market.

Looking ahead

We retain our constructive economic outlook, despite concerns around the Omicron variant. We acknowledge that the first quarter of 2022 could be challenging as the continued pandemic-related restrictions could lead to disappointing economic data. However, over a longer horizon, the prospect of another year with above-trend GDP growth and rising corporate earnings supports our pro-risk tilt in portfolios, while we continue to monitor inflation and normalising monetary and fiscal policy.

With rising interest rates, we will remain mindful of the value/growth rotation within equities. Despite a moderately higher interest rate outlook, real yields are likely to remain negative, which firstly favours our pro-risk stance, and secondly means we prefer credit to government bonds. Within credit, high yield will offer decent carry, and default rates remain low.

JPMorgan Multi-Asset Growth & Income plc (LON:MATE) combines sustainable income and capital growth from globally diversified investments. The Trust aims to achieve a long-term total return of 6% per annum and an initial annual dividend of 4% paid quarterly.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
X
LinkedIn

More articles like this

Analog Devices sees growth accelerating

Analog Devices expects annual revenue growth to average 7% to 10% over the next five years, the chip maker told analysts at a meeting Tuesday morning at the company’s headquarters near Boston. As the name implies, Analog

US FDA approves new Bristol Myers cancer immunotherapy

Bristol Myers Squibb Co said on Friday that U.S. regulators approved the first drug in a new class of cancer immunotherapies as an initial treatment for advanced melanoma, the deadliest form of skin cancer. The company

Procter & Gamble-owned Pantene partners with impressive female collective

THE WHAT? Procter & Gamble-owned Pantene has teamed up with ‘impressive, strong, modern, multi-hyphenate women’ to form the new Pantene Conditioner Collective. THE DETAILS Partners of the collective include Chloe Fineman, who features on Saturday Night Live and Dickinson, comedian Meg

Procter & Gamble’s sales jump

Shoppers shrugged off rising prices last year on products like Pampers diapers and Charmin toilet paper, Procter & Gamble said on Wednesday in announcing a jump in its second-quarter earnings. The consumer goods giant reported that

Abbvie looks to crack the cystic fibrosis code

When it comes to cystic fibrosis Vertex is the undisputed heavyweight, but this has not stopped other groups from taking it on. Abbvie is the latest challenger, and data due this quarter could give clues about

Italy to receive 40,000 Merck antiviral drug doses next week

Italy will receive around 40,000 doses of Merck & Co’s (MRK.N) COVID-19 antiviral drug next week, which will add to nearly 12,000 already distributed to hospitals, the special COVID-19 commissioner said on Sunday. “They are intended